{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T08:19:39Z","timestamp":1648628379440},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,2,10]],"date-time":"2013-02-10T00:00:00Z","timestamp":1360454400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s00520-013-1738-2","type":"journal-article","created":{"date-parts":[[2013,2,9]],"date-time":"2013-02-09T09:35:23Z","timestamp":1360402523000},"page":"1821-1826","source":"Crossref","is-referenced-by-count":2,"title":["Relationships between hepatitis B infection status and liver dysfunction after chemotherapy of lung cancer patients in mainland China"],"prefix":"10.1007","volume":"21","author":[{"given":"Huang","family":"Ruofan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhan","family":"Qiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhou","family":"Xinli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chu","family":"Zhaohui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang","family":"Jingwei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Xiaohua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,10]]},"reference":[{"key":"1738_CR1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1634\/theoncologist.6-2-162","volume":"6","author":"PD King","year":"2001","unstructured":"King PD, Perry MC (2001) Hepatotoxicity of chemotherapy. Oncologist 6:162\u2013176","journal-title":"Oncologist"},{"key":"1738_CR2","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1586\/17474124.2.4.553","volume":"2","author":"JH Kao","year":"2008","unstructured":"Kao JH (2008) Diagnosis of hepatitis B virus infection through serological and virological markers. Expert Rev Gastroenterol Hepatol 2:553\u2013562","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"1738_CR3","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.1016\/j.vaccine.2009.08.048","volume":"27","author":"X Liang","year":"2009","unstructured":"Liang X, Bi S, Yang W, Wang L, Cui G, Cui F et al (2009) Epidemiological serosurvey of hepatitis B in China\u2014declining HBV prevalence due to hepatitis B vaccination. Vaccine 27:6550\u20136557","journal-title":"Vaccine"},{"key":"1738_CR4","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s12072-008-9056-3","volume":"2","author":"GK Lau","year":"2008","unstructured":"Lau GK (2008) Hepatitis B reactivation after chemotherapy: two decades of clinical research. Hepatol Int 2:152\u2013162","journal-title":"Hepatol Int"},{"key":"1738_CR5","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S1470-2045(10)70197-2","volume":"11","author":"F Cainelli","year":"2010","unstructured":"Cainelli F, Vento S (2010) Time for universal HIV and HBV screening for patients with cancer. Lancet Oncol 11:916\u2013918","journal-title":"Lancet Oncol"},{"key":"1738_CR6","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1200\/JOP.2011.000450","volume":"8","author":"JP Hwang","year":"2011","unstructured":"Hwang JP, Fisch MJ, Zhang H, Kallen MA, Routbort MJ, Lal LS, Vierling JM, Suarez-Almazor ME (2011) Low rates of hepatitis B virus screening at the onset of chemotherapy. J Oncol Pract 8:e32\u2013e39","journal-title":"J Oncol Pract"},{"key":"1738_CR7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1471-2407-8-115","volume":"8","author":"F Wang","year":"2008","unstructured":"Wang F, Xu RH, Luo HY, Zhang DS, Jiang WQ, Huang HQ, Sun XF, Xia ZJ, Guan ZZ (2008) Clinical and prognostic analysis of hepatitis B virus infection in diffuse large B-cell lymphoma. BMC Cancer 8:115","journal-title":"BMC Cancer"},{"key":"1738_CR8","first-page":"459","volume":"32","author":"HY Zhang","year":"2010","unstructured":"Zhang HY, Liu ZG, Zhang Z, Gong HY (2010) Analysis of the prophylactic effect of nucleosides against reactivation of HBV in HBsAg-positive patients with non-hepatic tumors after chemotherapy. Zhonghua Zhong Liu Za Zhi 32:459\u2013462","journal-title":"Zhonghua Zhong Liu Za Zhi"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-013-1738-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-013-1738-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-013-1738-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T02:04:24Z","timestamp":1559095464000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-013-1738-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,10]]},"references-count":8,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["1738"],"URL":"https:\/\/doi.org\/10.1007\/s00520-013-1738-2","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,10]]}}}